Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Delivery of High‐Quality Biomarker Assays

1 Jan 2002

Abstract excerpt

Biomarker measurements now support key decisions throughout the drug development process, from lead optimization to regulatory approvals. They are essential for documenting exposure-response relationships, specificity and potency toward the molecular target, untoward effects, and therapeutic applications. In a broader sense, biomarkers constitute the basis of clinical pathology and laboratory medicine. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biosimilars and Bioanalytical Methods
Share to Statistical Methods in Clinical Trials

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 12364810
DOI: 10.1155/2002/212987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Delivery of High‐Quality Biomarker AssaysPMID 12364810Read ↗

In Pursuit of Greater Reproducibility and Credibility of Early Clinical Biomarker ResearchSemantic proximity Read ↗

Regulation of biomarker analysis: what can be translated in the clinic?Semantic proximity Read ↗

Study Design Considerations for Cancer Biomarker DiscoveriesSemantic proximity Read ↗

A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized TherapiesSemantic proximity Read ↗

Prospective–Retrospective Biomarker Analysis for Regulatory Consideration: white Paper from the Industry Pharmacogenomics Working GroupSemantic proximity Read ↗

Successes achieved and challenges ahead in translating biomarkers into clinical applications.Semantic proximity Read ↗

Translating genomic biomarkers into clinically useful diagnostics.Semantic proximity Read ↗

Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective.Semantic proximity Read ↗

Technology platforms for pharmacogenomic diagnostic assays.Semantic proximity Read ↗

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.Semantic proximity Read ↗

Biomarker discovery study design consistent with the Receiver-Operator CharacteristicSemantic proximity Read ↗

Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based DetectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.